Unknown

Dataset Information

0

Col4a3-/- Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 Backgrounds.


ABSTRACT: Alport syndrome (AS) is a hereditary renal disorder with no etiological therapy. In the preclinical Col4a3-/- model of AS, disease progression and severity vary depending on mouse strain. The sodium-glucose cotransporter 2 (SGLT2) is emerging as an attractive therapeutic target in cardiac/renal pathologies, but its application to AS remains untested. This study investigates cardiorespiratory function and SGLT2 renal expression in Col4a3-/- mice from three different genetic backgrounds, 129x1/SvJ, C57Bl/6 and Balb/C. male Col4a3-/- 129x1/SvJ mice displayed alterations consistent with heart failure with preserved ejection fraction (HFpEF). Female, but not male, C57Bl/6 and Balb/C Col4a3-/- mice exhibited mild changes in systolic and diastolic function of the heart by echocardiography. Male C57Bl/6 Col4a3-/- mice presented systolic dysfunction by invasive hemodynamic analysis. All strains except Balb/C males demonstrated alterations in respiratory function. SGLT2 expression was significantly increased in AS compared to WT mice from all strains. However, cardiorespiratory abnormalities and SGLT2 over-expression were significantly less in AS Balb/C mice compared to the other two strains. Systolic blood pressure was significantly elevated only in mutant 129x1/SvJ mice. The results provide further evidence for strain-dependent cardiorespiratory and hypertensive phenotype variations in mouse AS models, corroborated by renal SGLT2 expression, and support ongoing initiatives to develop SGLT2 inhibitors for the treatment of AS.

SUBMITTER: Irion CI 

PROVIDER: S-EPMC9223785 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>Col4a3<sup>-/-</sup></i> Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 Backgrounds.

Irion Camila I CI   Williams Monique M   Capcha Jose Condor JC   Eisenberg Trevor T   Lambert Guerline G   Takeuchi Lauro M LM   Seo Grace G   Yousefi Keyvan K   Kanashiro-Takeuchi Rosemeire R   Webster Keith A KA   Young Karen C KC   Hare Joshua M JM   Shehadeh Lina A LA  

International journal of molecular sciences 20220615 12


Alport syndrome (AS) is a hereditary renal disorder with no etiological therapy. In the preclinical <i>Col4a3<sup>-/-</sup></i> model of AS, disease progression and severity vary depending on mouse strain. The sodium-glucose cotransporter 2 (SGLT2) is emerging as an attractive therapeutic target in cardiac/renal pathologies, but its application to AS remains untested. This study investigates cardiorespiratory function and SGLT2 renal expression in <i>Col4a3<sup>-/-</sup></i> mice from three diff  ...[more]

Similar Datasets

| S-EPMC10674380 | biostudies-literature
| S-EPMC5355880 | biostudies-literature
| S-EPMC10743477 | biostudies-literature
2012-06-08 | GSE38359 | GEO
| S-EPMC4363017 | biostudies-literature
| S-EPMC10279852 | biostudies-literature
| S-EPMC4222035 | biostudies-literature
| S-EPMC7210116 | biostudies-literature
| S-EPMC2949544 | biostudies-literature
| S-EPMC9942641 | biostudies-literature